CCL2 and atherosclerosis: We decided to point our attention to BAF modulation of CCL2, as this chemokine has been already linked to BBB damage in several inflammatory and infectious disorders, such as atherosclerosis and MS (Gschwandtner et al. 2019), and also to S1P signaling (Li et al. 2014).